Equal-WT
WhaleScore 2.0
?
BVF is based out of San Francisco. BVF is a hedge fund with 5 clients and discretionary assets under management (AUM) of $4,498,633,095 (Form ADV from 2024-01-29). Their last reported 13F filing for Q4 2023 included $3,995,809,154 in managed 13F securities
and a top 10 holdings concentration of 61.89%. BVF's largest holding is MoonLake Immunotherapeutics with shares held of 21,751,284. Whalewisdom has at least 93 13F filings
2023-12-31
Top Buys (13F)
Name | % Change |
---|---|
KYMR Kymera Therapeutics, | 1.51% |
RVMD Revolution Medicines | 1.32% |
ACIU AC Immune SA | 1.25% |
SNDX Syndax Pharmaceutica | 1.01% |
KURA Kura Oncology Inc | 1% |
2023-12-31
Top Sells (13F)
Name | % Change |
---|---|
IDYA Ideaya Biosciences I | 2.3% |
PNT POINT Biopharma Glob | 1.9% |
IONS Ionis Phrmacutls | 1.82% |
GPCR Structure Therapeuti | 1.55% |
ACRS Aclaris Therapeutics | 1.31% |
2023-12-31
13F Holdings Summary
Name | $ Change |
---|---|
MLTX MoonLake Immunothera | 32.87% |
RVMD Revolution Medicines | 4.29% |
AXSM Axsome Therapeutics | 3.95% |
PTGX Protagonist Therapeu | 3.3% |
KYMR Kymera Therapeutics, | 3.29% |
2023-12-31
13F Activity
Market Value | $4.00b, Prior: $3.71b |
New Purchases | 7 stocks |
Added To | 10 stocks |
Sold out of | 6 stocks |
Reduced holdings in | 7 stocks |
Top 10 Holdings % | 61.89% |
Turnover %[1] | 18.57% |
Turnover Alt %[2] | 7.81% |
Time Held Top 20 | 5.75 quarters |
Time Held Top 10 | 2.2 quarters |
Time Held All | 10.36 quarters |
[1]: Turnover is calculated by taking the # of new holdings (initial purchases) + the # of positions sold out of (not just reduced) divided by the total # of holdings for the quarter.
[2]: Alt Turnover is calculated by taking either the total MV of new purchases or the MV of securities sold, whichever is less, divided by the total MV of the fund.
2023-12-31
13F Sector Allocation Over Time
2023-12-31
Analysis
Top 20 equal-weighted holdings. Performance numbers calculated through 2023-12-31